Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 5 Hodgkin Disease 5 Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Squamous Cell 3 Recurrence 2 Carcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Lymphoma, Large B-Cell, Diffuse 1 Laryngeal Diseases 1 Gliosarcoma 1 Glioblastoma 1 Disease 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

obinutuzumab 1 ioflupane 1 idelalisib 1 daratumumab 1 alovudine 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡